Dr Shahid Khan is a Consultant Physician at St Mary’s and Hammersmith Hospitals and a Clinical Senior Lecturer at Imperial College London, having been appointed in 2007. He is a Consultant in Gastroenterology with Specialist Accreditation in Hepatology.
Background Dr Khan graduated from Guy’s and St Thomas’ Hospitals Medical School in 1994. He completed specialist training in Gastroenterology, Hepatology and General Medicine in 2007 in North-West London and in 2003 he was awarded a PhD from the University of London for studies in liver cancer. Dr Khan became a Fellow of the Royal College of Physicians (FRCP) in 2010.
International Profile Dr Khan has lectured on liver and gastrointestinal disease nationally and internationally at Hepatology and Gastroenterology conferences. He is the lead author on the National guidelines for Biliary cancer and is an author on the International guidelines. Dr Khan has also delivered lectures on various aspects of liver and gastrointestinal disease at national and international conferences, including the British of Society Gastroenterology, British and European Associations for the Study of the Liver, the American Association for the Study of the Liver, the International Liver Cancer Association and the Royal Society of Medicine.
Research Dr Khan is the Academic Lead at Imperial College for Liver Cancer. He is also a Senior Lecturer at Imperial College London and his research interests include investigating early biomarkers in liver disease. He supervises several PhD/MD students. His other research areas include the epidemiology, aetiopathogenesis, metabolomic, proteomic and genomic analyses of liver cancer. He is recipient of several research grants. Dr Khan has published over 75 articles in the international medical literature.
Teaching Dr Khan is an accredited Royal College of Physicians Educator and has an extensive teaching portfolio. As well as supervising undergraduate and post graduate (PhD and MD) students, he is Director of Clinical Studies at the St Mary's Hospital Campus, Deputy Admissions Tutor for Imperial College Medical School, Module Co-Leader for the Gastroenterology BSc and Unit Training Director for the Department of Hepatology.
Professional Memberships for Dr Shahid A Khan include:
- American Association for the Study of the Liver Diseases (AASLD)
- British Association for the Study of the Liver (BASL)
- British Medical Association (BMA)
- British Society of Gastroenterology (BSG)
- European Association for the Study of the Liver (EASL)
- International Liver Cancer Association (ILCA)
- Medical Protection Society (MPS);
- (Fellow of) Royal College of Physicians (RCP, London)
et al., Ablative therapy for unresectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis, Journal of Clinical and Experimental Hepatology, ISSN:0973-6883
et al., 2019, Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma, European Journal of Cancer, Vol:116, ISSN:0959-8049, Pages:56-66
Khan SA, Tavolari S, Brandi G, 2019, Cholangiocarcinoma: Epidemiology and risk factors, Liver International, Vol:39, ISSN:1478-3223, Pages:19-31
et al., 2019, The emerging burden of liver disease in cystic fibrosis patients: a UK nationwide study, Plos One, Vol:14, ISSN:1932-6203
et al., 2019, Polymorphisms in natural killer cell receptor protein 2D (NKG2D) as a risk factor for Cholangiocarcinoma, Journal of Clinical and Experimental Hepatology, Vol:9, ISSN:0973-6883, Pages:171-175